Thyrocare reported audited standalone FY26 revenue of ₹774.27 crore and net profit of ₹148.81 crore, with a 55% YoY profit growth.
The Board recommended a final dividend of ₹7 per equity share for FY26, subject to shareholder approval.
Exceptional items of ₹5.97 crore were recorded due to new labour code impacts and capital restructuring costs.
Consolidated FY26 revenue reached ₹829.04 crore with net profit of ₹162.85 crore attributable to owners.